Showing 6841-6850 of 18626 results for "".
Additional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
https://reachmd.com/clinical-practice/oncology-hematology/additional-safey-data-from-tropion-breast02-and-study-design-of-tropion-breast06/49125/Learn how TROPION-Breast02 and TROPION-Breast06 are shaping the role of Dato-DXd in mTNBC and chemo-naïve HR+/HER2- mBC, respectively.Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/How can you diagnose patients with SHPT earlier in CKD and control PTH levels early in the disease course? Our experts have what you need to know!Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
https://reachmd.com/programs/cme/optimizing-the-care-and-quality-of-life-for-patients-with-adpkd-part-4-emerging-therapies/12680/How can you use emerging therapeutic options to treat patients with autosomal dominant polycystic kidney disease?Second Ebola Virus Treatment Approved
https://reachmd.com/programs/the-drug-report/second-ebola-virus-treatment-approved/12120/The FDA announced approval for a second ebolavirus treatment nearly seven years after the largest Ebola epidemic in West Africa.Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
https://reachmd.com/programs/cme/data-driving-preferred-guideline-recommendations-in-first-line-therapy-for-metastatic-melanoma/36327/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Fibrodysplasia Ossificans Progressiva: Mechanism of Disease
https://reachmd.com/programs/medical-industry-feature/fibrodysplasia-ossificans-progressiva-mechanism-of-disease/36114/Fibrodysplasia ossificans progressiva (FOP) is a severely disabling myopathy in which extraskeletal bone forms and accumulates over time within muscles and soft tissues.1,2 Here’s what we know so far about the mechanisms of heterotopic ossification in patients with FOP. References: Kaplan FS et al.Advancing Heart Failure Treatment With Barostim: An Electrophysiologist’s Real-World Success Story
https://reachmd.com/programs/cme/advancing-heart-failure-treatment-with-barostim-an-electrophysiologists-real-world-success-story/29821/Dr. Verma provides expert guidance based on real-world data and personal experience to help you ensure successful use of the Barostim device.Exploring COPD Exacerbations Through the Lens of a Patient Case
https://reachmd.com/programs/deep-breaths-updates-chest/exploring-copd-exacerbations-through-the-lens-of-a-patient-case/14162/Learn more about the pathophysiology behind COPD exacerbations and the factors that may put our patients at risk.Therapies & Vaccines on the Horizon for COVID-19
https://reachmd.com/programs/the-drug-report/therapies-vaccines-on-the-horizon-for-covid-19/11288/After much research activity has been devoted to finding a vaccine and cure for COVID-19, could there finally be hope amid this global pandemic?A Deep Dive into the Management of AEs Associated with ADCs
https://reachmd.com/programs/cme/a-deep-dive-into-the-management-of-aes-associated-with-adcs/13767/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!